
IntelGenx Technologies Corp.
IntelGenx Technologies Corp. (IGXT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IGXT · as of Jun 8, 2026
Key Statistics
Explore IntelGenx Technologies Corp. Data
igxt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
igxt competitorsStock Performance
Full HistoryAbout IntelGenx Technologies Corp.
IntelGenx Technologies Corp. operates as a specialized drug delivery firm, concentrating on the creation and production of innovative oral thin film products for the pharmaceutical industry. Their cur…
what is intelgenx technologies corp. · igxt stock overview · intelgenx technologies corp. company profile · who is intelgenx technologies corp. ceo · igxt OTC · intelgenx technologies corp. headquarters · intelgenx technologies corp. business segments
About Stock Overview & Key Data
IntelGenx Technologies Corp. (IGXT) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 17, 2007. As of the latest trading session, IGXT stock price is $0.17, with a market capitalization of $29.7M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 2 Wall Street analysts, the consensus rating for IntelGenx Technologies Corp. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, IntelGenx Technologies Corp. reported revenue of $1.0M and net income of -$9.9M. For detailed data — including IntelGenx Technologies Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IntelGenx Technologies Corp. (IGXT) stock price is $0.17. The stock is traded on OTC under the ticker symbol IGXT. The 52-week range is $0.16 – $0.17.